Rational Design of Polymeric mRNA Delivery Vectors to Achieve Excellent Room-Temperature Storage Stability and Delivery Efficiency

Delivery vectors play an important role in delivering mRNA. However, it is an important challenge to enhance room-temperature storage stability and balance the conflicting requirements for excellent in vivo stability and mRNA release performance. In response to the above problems, we propose a “4Q”...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemistry of materials 2024-05, Vol.36 (11), p.5422-5435
Hauptverfasser: Shi, Junqiu, Yin, Haiyang, Sun, Qingmei, Teng, Runxin, Zhu, Yunqing, Du, Jianzhong
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Delivery vectors play an important role in delivering mRNA. However, it is an important challenge to enhance room-temperature storage stability and balance the conflicting requirements for excellent in vivo stability and mRNA release performance. In response to the above problems, we propose a “4Q” principle for designing mRNA delivery vectors. The overall delivery efficiency (Q) of mRNA is related to the stability of the delivery vector itself (Q S , including storage stability and in vivo stability which was rarely considered previously), the performance of diffusion to the target cells (Q D ), the ability to enter the cytoplasm through the cell membrane (Q I ), and the performance of the intracellular release of mRNA (Q R ). The efficiencies of each step are crucial to high overall delivery efficiency of intramuscular injection. Based on this “4Q” principle, we designed a new cationic polycatechol, poly­(N,N′-bis­(acryloyl)­cystamine-co-dopamine) (PBD). The PBD/mRNA polyplexes are stable at room temperature for more than 2 weeks (Q S ↑). The in vivo transfection fluorescence intensity of polyplexes was 2 orders of magnitude higher than the commercially available mRNA delivery system (e.g., jetPEI/mRNA). Overall, this new “4Q” principle will be helpful for designing clinically transformative mRNA vectors with excellent storage stability and delivery efficiency.
ISSN:0897-4756
1520-5002
DOI:10.1021/acs.chemmater.4c00219